347 related articles for article (PubMed ID: 22403576)
21. Bone marrow findings in HIV-positive patients with Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Venkataraman G; Uldrick TS; Aleman K; O'Mahony D; Karcher DS; Steinberg SM; Raffeld MA; Marshall V; Whitby D; Little RF; Yarchoan R; Pittaluga S; Maric I
Am J Clin Pathol; 2013 May; 139(5):651-61. PubMed ID: 23596117
[TBL] [Abstract][Full Text] [Related]
22. Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment.
Bhutani M; Polizzotto MN; Uldrick TS; Yarchoan R
Semin Oncol; 2015 Apr; 42(2):223-46. PubMed ID: 25843728
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
Lurain K; Yarchoan R; Uldrick TS
Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
[TBL] [Abstract][Full Text] [Related]
24. Multicentric Castleman disease: Where are we now?
Wang HW; Pittaluga S; Jaffe ES
Semin Diagn Pathol; 2016 Sep; 33(5):294-306. PubMed ID: 27296355
[TBL] [Abstract][Full Text] [Related]
25. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.
Oksenhendler E; Boulanger E; Galicier L; Du MQ; Dupin N; Diss TC; Hamoudi R; Daniel MT; Agbalika F; Boshoff C; Clauvel JP; Isaacson PG; Meignin V
Blood; 2002 Apr; 99(7):2331-6. PubMed ID: 11895764
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases.
Ramaswami R; Lurain K; Polizzotto MN; Ekwede I; Waldon K; Steinberg SM; Mangusan R; Widell A; Rupert A; George J; Gonçalves PH; Marshall VA; Whitby D; Wang HW; Pittaluga S; Jaffe ES; Little RF; Uldrick TS; Yarchoan R
Blood Adv; 2021 Mar; 5(6):1660-1670. PubMed ID: 33720337
[TBL] [Abstract][Full Text] [Related]
27. The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa.
Blumenthal MJ; Schutz C; Barr D; Locketz M; Marshall V; Whitby D; Katz AA; Uldrick T; Meintjes G; Schäfer G
J Infect Dis; 2019 Jul; 220(5):841-851. PubMed ID: 31004430
[TBL] [Abstract][Full Text] [Related]
28. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.
Sakakibara S; Tosato G
J Interferon Cytokine Res; 2011 Nov; 31(11):791-801. PubMed ID: 21767154
[TBL] [Abstract][Full Text] [Related]
29. High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
Uldrick TS; Polizzotto MN; Aleman K; O'Mahony D; Wyvill KM; Wang V; Marshall V; Pittaluga S; Steinberg SM; Tosato G; Whitby D; Little RF; Yarchoan R
Blood; 2011 Jun; 117(26):6977-86. PubMed ID: 21487108
[TBL] [Abstract][Full Text] [Related]
30. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy.
Corbellino M; Bestetti G; Scalamogna C; Calattini S; Galazzi M; Meroni L; Manganaro D; Fasan M; Moroni M; Galli M; Parravicini C
Blood; 2001 Dec; 98(12):3473-5. PubMed ID: 11719390
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
[TBL] [Abstract][Full Text] [Related]
32. Multicentric Castleman disease and the evolution of the concept.
Zhou T; Wang HW; Pittaluga S; Jaffe ES
Pathologica; 2021 Oct; 113(5):339-353. PubMed ID: 34837092
[TBL] [Abstract][Full Text] [Related]
33. Human herpesvirus 8+ polyclonal IgMλ B-cell lymphocytosis mimicking plasmablastic leukemia/lymphoma in HIV-infected patients.
Oksenhendler E; Boutboul D; Beldjord K; Meignin V; de Labarthe A; Fieschi C; Dossier A; Agbalika F; Parravicini C; Tosato G; Gérard L; Galicier L
Eur J Haematol; 2013 Dec; 91(6):497-503. PubMed ID: 23992152
[TBL] [Abstract][Full Text] [Related]
34. Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.
Caro-Vegas C; Sellers S; Host KM; Seltzer J; Landis J; Fischer WA; Damania B; Dittmer DP
Virology; 2020 Jan; 539():18-25. PubMed ID: 31629226
[TBL] [Abstract][Full Text] [Related]
35. Castleman disease.
Carbone A; Borok M; Damania B; Gloghini A; Polizzotto MN; Jayanthan RK; Fajgenbaum DC; Bower M
Nat Rev Dis Primers; 2021 Nov; 7(1):84. PubMed ID: 34824298
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.
Soulier J; Grollet L; Oksenhendler E; Cacoub P; Cazals-Hatem D; Babinet P; d'Agay MF; Clauvel JP; Raphael M; Degos L
Blood; 1995 Aug; 86(4):1276-80. PubMed ID: 7632932
[TBL] [Abstract][Full Text] [Related]
37. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
38. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.
Uldrick TS; Polizzotto MN; Aleman K; Wyvill KM; Marshall V; Whitby D; Wang V; Pittaluga S; O'Mahony D; Steinberg SM; Little RF; Yarchoan R
Blood; 2014 Dec; 124(24):3544-52. PubMed ID: 25331113
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease.
Martin de Frémont G; Vanjak A; Sbihi Z; Knapp S; Garzaro M; Chbihi M; Fournier B; Poirot J; Dossier A; Silvestrini MA; Villemonteix J; Meignin V; Galicier L; Bertinchamp R; Le Goff J; Salmona M; Flamarion E; Cassius C; Lebbé C; Ronchetti AM; Latour S; Oksenhendler E; Carcelain G; Boutboul D
Blood Adv; 2023 May; 7(9):1682-1691. PubMed ID: 36508281
[TBL] [Abstract][Full Text] [Related]
40. Cytokine-Targeted Therapeutics for KSHV-Associated Disease.
Alomari N; Totonchy J
Viruses; 2020 Sep; 12(10):. PubMed ID: 32998419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]